Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Neurotech Lobby Seeks $200 Million From Congress

This article was originally published in The Gray Sheet

Executive Summary

The Neurotechnology Industry Organization says it is mustering support in Congress for its proposed National Neurotechnology Initiative Act, which would appropriate about $200 million of federal money annually for the advancement of technologies to treat brain diseases

You may also be interested in...



Correction

Zack Lynch is executive director of the Neurotechnology Industry Organization. "The Gray Sheet" incorrectly identified Lynch's first name in the May 28 issue (1"The Gray Sheet" May 28, 2007, p. 20)...

Correction

Zack Lynch is executive director of the Neurotechnology Industry Organization. "The Gray Sheet" incorrectly identified Lynch's first name in the May 28 issue (1"The Gray Sheet" May 28, 2007, p. 20)...

Neurotechnology Interests Form New Trade Association To Lobby Congress

A newly formed trade association called the Neurotechnology Industry Organization (NIO) will seek greater government support for the development of therapies for brain and nervous system diseases

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel